Betsy J Barnes1. 1. Center for Autoimmune Musculoskeletal and Hematopoietic Diseases, Northwell Health, Feinstein Institute for Medical Research, Hofstra-Northwell School of Medicine, 350 Community Dr, Hempstead, NY, 11030, USA. bbarnes1@northwell.edu.
Abstract
PURPOSE OF REVIEW: Systemic lupus erythematosus (SLE) is characterized by a breakdown of immune tolerance, resulting in inflammation and tissue destruction. While the primary causes of SLE are still obscure, the disorder is highly heritable. Genetic risk variants, on their own, are rarely causal or fully explain disease pathogenesis. We discuss the possibility that IRF5, a SLE susceptibility gene, has both genetic and non-genetic contributions to disease pathogenesis. RECENT FINDINGS: Genetic variants within and around IRF5 robustly associate with SLE risk. In SLE blood cells, IRF5 risk variants associate with elevated IRF5 expression and IFN production. Whether the observed increase in expression is due to risk variants or other disease-associated factors is not clear. Data from Irf5-/- mice backcrossed to multiple models of murine lupus support that IRF5's role in disease pathogenesis is non-genetic. Studies of IRF5 expression and function in genotyped healthy donors will address the question of whether IRF5 dysregulation in SLE is driven by genetic or non-genetic factors.
PURPOSE OF REVIEW: Systemic lupus erythematosus (SLE) is characterized by a breakdown of immune tolerance, resulting in inflammation and tissue destruction. While the primary causes of SLE are still obscure, the disorder is highly heritable. Genetic risk variants, on their own, are rarely causal or fully explain disease pathogenesis. We discuss the possibility that IRF5, a SLE susceptibility gene, has both genetic and non-genetic contributions to disease pathogenesis. RECENT FINDINGS: Genetic variants within and around IRF5 robustly associate with SLE risk. In SLE blood cells, IRF5 risk variants associate with elevated IRF5 expression and IFN production. Whether the observed increase in expression is due to risk variants or other disease-associated factors is not clear. Data from Irf5-/- mice backcrossed to multiple models of murine lupus support that IRF5's role in disease pathogenesis is non-genetic. Studies of IRF5 expression and function in genotyped healthy donors will address the question of whether IRF5 dysregulation in SLE is driven by genetic or non-genetic factors.
Authors: Thomas Krausgruber; Katrina Blazek; Tim Smallie; Saba Alzabin; Helen Lockstone; Natasha Sahgal; Tracy Hussell; Marc Feldmann; Irina A Udalova Journal: Nat Immunol Date: 2011-01-16 Impact factor: 25.606
Authors: Betsy J Barnes; Merrill J Kellum; Karen E Pinder; J Augusto Frisancho; Paula M Pitha Journal: Cancer Res Date: 2003-10-01 Impact factor: 12.701
Authors: Sergey V Kozyrev; Susanna Lewén; Prasad M V Linga Reddy; Bernardo Pons-Estel; Torsten Witte; Peter Junker; Helle Laustrup; Carmen Gutiérrez; Ana Suárez; Maria Francisca González-Escribano; Javier Martín; Marta E Alarcón-Riquelme Journal: Arthritis Rheum Date: 2007-04
Authors: Robert R Graham; Chieko Kyogoku; Snaevar Sigurdsson; Irina A Vlasova; Leela R L Davies; Emily C Baechler; Robert M Plenge; Thearith Koeuth; Ward A Ortmann; Geoffrey Hom; Jason W Bauer; Clarence Gillett; Noel Burtt; Deborah S Cunninghame Graham; Robert Onofrio; Michelle Petri; Iva Gunnarsson; Elisabet Svenungsson; Lars Rönnblom; Gunnel Nordmark; Peter K Gregersen; Kathy Moser; Patrick M Gaffney; Lindsey A Criswell; Timothy J Vyse; Ann-Christine Syvänen; Paul R Bohjanen; Mark J Daly; Timothy W Behrens; David Altshuler Journal: Proc Natl Acad Sci U S A Date: 2007-04-05 Impact factor: 11.205
Authors: Kei Yasuda; Amanda A Watkins; Guneet S Kochar; Gabriella E Wilson; Bari Laskow; Christophe Richez; Ramon G Bonegio; Ian R Rifkin Journal: PLoS One Date: 2014-07-30 Impact factor: 3.240
Authors: Dan Li; Bharati Matta; Su Song; Victoria Nelson; Kirsten Diggins; Kim R Simpfendorfer; Peter K Gregersen; Peter Linsley; Betsy J Barnes Journal: JCI Insight Date: 2020-01-30
Authors: Kwang Seob Lee; Andreas Kronbichler; Daniel Fernando Pereira Vasconcelos; Felipe Rodolfo Pereira da Silva; Younhee Ko; Yeon Su Oh; Michael Eisenhut; Peter A Merkel; David Jayne; Christopher I Amos; Katherine A Siminovitch; Chinar Rahmattulla; Keum Hwa Lee; Jae Il Shin Journal: J Clin Med Date: 2019-02-21 Impact factor: 4.241
Authors: Helena Idborg; Arash Zandian; Elena Ossipova; Edvard Wigren; Charlotta Preger; Fariborz Mobarrez; Antonio Checa; Azita Sohrabian; Pascal Pucholt; Johanna K Sandling; Cátia Fernandes-Cerqueira; Johan Rönnelid; Vilija Oke; Giorgia Grosso; Marika Kvarnström; Anders Larsson; Craig E Wheelock; Ann-Christine Syvänen; Lars Rönnblom; Kim Kultima; Helena Persson; Susanne Gräslund; Iva Gunnarsson; Peter Nilsson; Elisabet Svenungsson; Per-Johan Jakobsson Journal: Front Immunol Date: 2019-05-17 Impact factor: 7.561
Authors: Jaspreet Banga; Dinesh Srinivasan; Chia-Chi Sun; Cherrie D Thompson; Francesca Milletti; Kuo-Sen Huang; Shannon Hamilton; Su Song; Ann F Hoffman; Yajuan Gu Qin; Bharati Matta; Margaret LaPan; Qin Guo; Gang Lu; Dan Li; Hong Qian; David R Bolin; Lena Liang; Charles Wartchow; Jin Qiu; Michelle Downing; Satwant Narula; Nader Fotouhi; Julie A DeMartino; Seng-Lai Tan; Gang Chen; Betsy J Barnes Journal: Sci Adv Date: 2020-05-15 Impact factor: 14.136
Authors: Xingwang Zhao; Longlong Zhang; Juan Wang; Min Zhang; Zhiqiang Song; Bing Ni; Yi You Journal: J Transl Med Date: 2021-01-19 Impact factor: 5.531
Authors: Alex Pellerin; Kei Yasuda; Abraham Cohen-Bucay; Vanessa Sandra; Prachi Shukla; Barry K Horne Jr; Kerstin Nündel; Gregory A Viglianti; Yao Xie; Ulf Klein; Ying Tan; Ramon G Bonegio; Ian R Rifkin Journal: JCI Insight Date: 2021-08-09